Se-Hwan Han
Overview
Explore the profile of Se-Hwan Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
65
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Noh W, Nam S, Park B, Lee E, Im S, et al.
Eur J Cancer
. 2021 May;
151:190-200.
PMID: 34010788
Background: Adding ovarian function suppression (OFS) after chemotherapy improves survival in young women with moderate- and high-risk breast cancer. Assessment of ovarian function restoration after chemotherapy becomes critical for subsequent...
2.
Kim H, Lee J, Nam S, Park B, Im S, Lee E, et al.
J Clin Oncol
. 2019 Sep;
38(5):434-443.
PMID: 31518174
Purpose: The addition of ovarian function suppression (OFS) for 5 years to tamoxifen (TAM) for treatment of premenopausal patients with breast cancer after completion of chemotherapy has beneficial effects on...
3.
Lee J, Hur H, Lee J, Youn H, Han K, Kim N, et al.
Cancer
. 2019 Aug;
126(1):181-188.
PMID: 31454422
Background: There is a controversy about late-onset congestive heart failure (CHF) among breast cancer survivors. This study investigated the incidence rate and risk factors of late-onset CHF more than 2 ...
4.
Kim H, Ahn S, Nam S, Park S, Ro J, Im S, et al.
BMC Cancer
. 2016 May;
16:319.
PMID: 27197523
Background: Ovarian function suppression (OFS) has been shown to be effective as adjuvant endocrine therapy in premenopausal women with hormone receptor-positive breast cancer. However, it is currently unclear if addition...